• Login
    View Item 
    •   DSpace@RPI Home
    • Rensselaer Libraries
    • RPI Theses Online (Complete)
    • View Item
    •   DSpace@RPI Home
    • Rensselaer Libraries
    • RPI Theses Online (Complete)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Development of a phosphoproteomic workflow for the analysis of Chinese hamster ovary cell nuclei

    Author
    Khan, Mahwish
    View/Open
    167243_Khan_rpi_0185N_10038.pdf (990.8Kb)
    Other Contributors
    Platt, Mark D.; Bailey, R. A. (Ronald Albert), 1933-; Breneman, Curt M.;
    Date Issued
    2013-05
    Subject
    Chemistry
    Degree
    MS;
    Terms of Use
    This electronic version is a licensed copy owned by Rensselaer Polytechnic Institute, Troy, NY. Copyright of original work retained by author.;
    Metadata
    Show full item record
    URI
    https://hdl.handle.net/20.500.13015/904
    Abstract
    Phosphorylation of nuclear proteins has been widely recognized as a key chemical modification necessary for the control of mRNA transcription. Thus, the exact phosphorylation sites of nuclear proteins will be especially useful for revealing the molecular mechanisms that affect transcription in high producing cell lines and may be used to manipulate transcription rates. The challenge lies in the complexity of the nuclear proteome and in ensuring that upstream sample preparation is compatible with downstream analysis. In the current work the goal was to develop a solution based workflow to identify nuclear phosphoproteins with methods that are amenable to mass spectrometric analysis and to identify phosphorylated proteins in the nucleus of an industrially relevant cell line. By using proteomics approaches such as sample-clean up procedures, affinity chromatography and high sensitivity mass spectrometric based peptide sequencing, we have identified over 70 phosphorylation sites on 38 proteins in a CHO cell line.; Monoclonal antibodies are essential for the treatment of a wide variety of human diseases such as colon cancer and arthritis. Because of the complexity of monoclonal antibodies and the need for proper post-translational modifications (PTMs), mammalian host cells are used to create recombinant proteins that are fully functional in human targets. For more than twenty years, the leading host cells for protein therapeutics have been Chinese hamster ovary (CHO) cells because they are amenable to large scale culture conditions and are easily transfected with target DNA. Although CHO cells are widely used, the current selection process for high producing lines requires the testing of growth conditions for hundreds of cell lines in order to determine their productivity rates, which can be costly and time consuming. An alternative option for cell line selection that has not been fully explored is the screening of cell lines for protein markers such as transcriptional factors that are up- or down-regulated. This could potentially lead to more rapid selection criteria and increased production of recombinant proteins.;
    Description
    May 2013; School of Science
    Department
    Dept. of Chemistry and Chemical Biology;
    Publisher
    Rensselaer Polytechnic Institute, Troy, NY
    Relationships
    Rensselaer Theses and Dissertations Online Collection;
    Access
    Restricted to current Rensselaer faculty, staff and students. Access inquiries may be directed to the Rensselaer Libraries.;
    Collections
    • RPI Theses Online (Complete)

    Browse

    All of DSpace@RPICommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    DSpace software copyright © 2002-2022  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV